Effects of other deprivation

ST19_EFFEC_OTHER_DEPRI

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519870
1. Apply sex-specific rule None	519870
2. Check conditions None	519870
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T73 Cause of death: ICD-10 — T73 2 out of 7 registries used, show all original rules.	95
4. Check minimum number of events None	95
5. Include endpoints None	95
6. Filter based on genotype QC (FinnGen only)	91

Control definitions (FinnGen only)

Control exclude: ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: T6[6-9]|T7[0-8]
Name in latin: Effectus aliarum privationum

NAME	ST19_EFFEC_OTHER_DEPRI
CONTROL_EXCLUDE	ST19_OTHER_UNSPE_EFFEC_EXTER_CAUSES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T73
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T73
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Effects of other deprivation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	91	56	35
Unadjusted period prevalence (%)	0.02	0.02	0.02
Median age at first event (years)	38.08	40.55	34.11

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
95: Matched controls
950

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

T73.3

ICD-10 Finland

Exhaustion due to excessive exertion

2821.3

90.5

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.1

7.8

T73.9

ICD-10 Finland

Effect of deprivation, unspecified

+∞

6.3

T73.0

ICD-10 Finland

Effects of hunger

+∞

6.3

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

16.4

6.0

TimeCodeWAS

↥

TODO / Current known limitations:

Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
Legend / how to read the glyphs.
Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
Download CSV.
No filters and sorters.
Limited amount of endpoints (~400) having TimeCodeWAS data.
Cross-links to Risteys lab test pages for lab test codes.

OMOP concept

ln(OR)

%cases with code / %controls with code

2×2 table

Psychiatry
26 [38004469]

1.2e+00

9.6e-01

—

1.9e+00

1.5e+00

cases:14.74%

controls:5.16%

cases:7.37%

controls:2.95%

—

cases:8.42%

controls:1.37%

cases:14.89%

controls:2.55%

cases:24.44%

controls:6.99%

901

922

—

937

919

838

citalopram; oral, parenteral
N06AB04 [21604712]

1.6e+00

1.5e+00

—

2.0e+00

1.5e+00

cases:9.47%

controls:2.11%

cases:6.32%

controls:1.47%

—

cases:8.51%

controls:1.27%

cases:12.22%

controls:3.00%

930

936

—

931

874

Inpatient Hospital
21 [8717]

7.5e-01

8.9e-01

1.7e+00

—

1.8e+00

1.1e+00

6.9e-01

cases:48.42%

controls:30.74%

cases:23.16%

controls:11.05%

cases:6.32%

controls:1.26%

—

cases:8.42%

controls:1.47%

cases:23.40%

controls:9.44%

cases:46.67%

controls:30.52%

292

658

105

845

938

—

936

854

275

626

Emergency Room Visit
ER [9203]

6.2e-01

8.0e-01

2.7e+00

—

1.7e+00

9.1e-01

7.6e-01

cases:37.89%

controls:24.63%

cases:20.00%

controls:10.11%

cases:7.37%

controls:0.53%

—

cases:5.26%

controls:1.05%

cases:19.15%

controls:8.70%

cases:48.89%

controls:30.85%

234

716

854

945

—

940

861

278

623

Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]

—

2.2e+00

8.0e-01

—

cases:6.38%

controls:0.74%

cases:12.22%

controls:5.88%

—

936

848

CBC panel - Blood by Automated count
58410-2 [40761511]

4.3e-01

3.5e-01

2.2e+00

—

4.4e-01

3.2e-01

cases:13.68%

controls:9.37%

cases:11.58%

controls:8.42%

cases:6.32%

controls:0.74%

—

cases:11.70%

controls:7.85%

cases:25.56%

controls:19.98%

861

870

943

—

869

180

721

Neurology
13 [38004458]

1.1e+00

8.6e-01

—

1.0e+50

—

1.0e+00

1.1e+00

cases:15.79%

controls:5.89%

cases:7.37%

controls:3.26%

—

cases:7.37%

controls:0.00%

—

cases:7.45%

controls:2.76%

cases:20.00%

controls:7.77%

894

919

—

950

—

917

831

Dizziness and giddiness
R42 [45568132]

—

2.1e+00

—

cases:6.67%

controls:0.89%

—

893

General Practice
1 [38004446]

6.0e-01

1.2e+00

—

1.0e+50

—

2.1e+00

8.6e-01

cases:15.79%

controls:9.37%

cases:9.47%

controls:3.05%

—

cases:25.26%

controls:0.00%

—

cases:17.02%

controls:2.55%

cases:20.00%

controls:9.54%

861

921

—

950

—

919

815

Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]

—

2.0e+00

—

cases:11.11%

controls:1.66%

—

886

Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]

—

2.0e+00

8.7e-01

—

cases:8.51%

controls:1.27%

cases:11.11%

controls:4.99%

—

931

856

Physiotherapy
R4110 [2001310233]

—

1.8e+00

—

cases:7.78%

controls:1.33%

—

889

Epithelial cells [#/volume] in Urine
30383-4 [3000850]

—

1.8e+00

—

cases:8.89%

controls:1.55%

—

887

Dyspnoea
R06.0 [45558449]

—

1.8e+00

—

cases:10.00%

controls:1.78%

—

885

Bacteria [Presence] in Urine
87829-8 [36304419]

—

1.8e+00

—

cases:10.00%

controls:1.89%

—

884

Right side
ZXA00 [2001311346]

—

-1.0e+50

—

1.7e+00

—

cases:0.00%

controls:1.37%

—

cases:8.89%

controls:1.66%

—

937

—

886

doxycycline; oral, parenteral
J01AA02 [21602800]

2.1e-01

1.7e+00

—

3.6e-01

4.9e-01

cases:22.11%

controls:18.74%

cases:17.89%

controls:3.68%

—

cases:7.45%

controls:5.30%

cases:24.44%

controls:16.54%

178

772

915

—

893

149

752

Outpatient Visit
OP [9202]

3.8e-01

1.4e-01

2.7e-01

—

9.6e-01

7.5e-01

9.7e-01

cases:57.89%

controls:48.53%

cases:36.84%

controls:33.58%

cases:9.47%

controls:7.37%

—

cases:18.95%

controls:8.21%

cases:52.13%

controls:34.04%

cases:82.22%

controls:63.71%

461

489

319

631

880

—

872

321

622

574

327

Malaise and fatigue
R53 [45553741]

2.0e+00

—

1.7e+00

cases:5.26%

controls:0.74%

—

cases:8.89%

controls:1.78%

943

—

885

Pharmacy visit
OMOP4822462 [581458]

1.5e-01

4.9e-01

8.0e-01

1.2e+00

8.4e-01

3.3e-01

5.6e-01

cases:90.53%

controls:89.16%

cases:82.11%

controls:73.68%

cases:49.47%

controls:30.53%

cases:5.26%

controls:1.68%

cases:49.47%

controls:29.68%

cases:80.85%

controls:75.19%

cases:95.56%

controls:92.45%

847

103

700

250

290

660

934

282

668

709

234

833

Casts [#/volume] in Urine by Automated count
51483-6 [3030467]

—

1.6e+00

—

cases:10.00%

controls:2.22%

—

881

More than one and less than three hours
ZXE10 [2001311401]

1.1e+00

—

1.5e+00

cases:7.37%

controls:2.53%

—

cases:10.00%

controls:2.33%

926

—

880

Erythrocytes [#/volume] in Urine
30391-7 [3002582]

—

1.5e+00

—

cases:11.11%

controls:2.66%

—

877

oxazepam; oral
N05BA04 [21604569]

1.0e+00

1.4e+00

—

1.6e+00

1.5e+00

cases:8.42%

controls:3.16%

cases:6.32%

controls:1.68%

—

cases:8.51%

controls:1.80%

cases:15.56%

controls:4.00%

920

934

—

926

865

Scheduled procedure
ZXD10 [2001311387]

9.8e-01

—

1.3e+00

cases:9.47%

controls:3.79%

—

cases:12.22%

controls:3.55%

914

—

869

mirtazapine; oral
N06AX11 [21604740]

7.2e-01

1.4e+00

—

1.7e+00

1.3e+00

cases:5.26%

controls:2.63%

cases:5.26%

controls:1.37%

—

cases:7.45%

controls:1.38%

cases:14.44%

controls:4.44%

925

937

—

930

861

Physical Medicine And Rehabilitation
25 [38004468]

—

1.2e+00

—

cases:14.44%

controls:4.66%

—

859

Outpatient Hospital
22 [8756]

3.8e-01

1.1e+00

—

5.1e-01

3.8e-01

cases:27.37%

controls:20.53%

cases:15.79%

controls:6.00%

—

cases:8.51%

controls:5.30%

cases:28.89%

controls:21.75%

195

755

893

—

893

196

705

Internal Medicine
11 [38004456]

5.1e-01

6.0e-01

—

1.6e+00

1.0e+00

4.7e-01

cases:24.21%

controls:16.11%

cases:13.68%

controls:8.00%

—

cases:7.37%

controls:1.58%

cases:20.21%

controls:8.27%

cases:28.89%

controls:20.31%

153

797

874

—

935

865

183

718

General Surgery
2 [38004447]

9.3e-02

5.7e-01

—

8.8e-01

8.3e-01

cases:16.84%

controls:15.58%

cases:8.42%

controls:4.95%

—

cases:11.70%

controls:5.20%

cases:35.56%

controls:19.42%

148

802

903

—

894

175

726

hydroxychloroquine; oral
P01BA02 [21604889]

-1.0e+50

—

cases:0.00%

controls:0.63%

—

944

—

Triglyceride [Moles/volume] in Serum or Plasma
14927-8 [3025839]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.53%

cases:0.00%

controls:0.95%

—

cases:0.00%

controls:0.64%

—

945

941

—

937

—

pentoxyverine; oral, rectal
R05DB05 [21603414]

—

-1.0e+50

—

cases:0.00%

controls:0.67%

—

895

Contusion of other and unspecified parts of foot
S90.3 [45584475]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

duloxetine; oral
N06AX21 [21604749]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

cases:0.00%

controls:0.89%

—

938

893

Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]

3.4e-01

9.6e-02

—

1.0e+50

—

8.8e-01

4.2e-01

cases:9.47%

controls:6.95%

cases:7.37%

controls:6.74%

—

cases:5.26%

controls:0.00%

—

cases:12.77%

controls:5.73%

cases:22.22%

controls:15.76%

884

886

—

950

—

889

142

759

desloratadine; oral
R06AX27 [21603526]

—

5.7e-01

—

cases:6.67%

controls:3.88%

—

866

Basic examination of mouth
SAA02 [2001310275]

5.0e-01

—

1.1e-01

cases:10.53%

controls:6.63%

—

cases:14.44%

controls:13.10%

887

—

118

783

tiotropium bromide; inhalant
R03BB04 [21603296]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.53%

cases:0.00%

controls:0.53%

—

cases:0.00%

controls:0.74%

—

945

—

936

—

Lateral epicondylitis
M77.1 [45572551]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.63%

—

cases:0.00%

controls:0.89%

944

—

893

Tinnitus
H93.1 [45543152]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Pregnancy symptom/complaint other
W29 [2002001222]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

plastic IUD with progestogen; implant
G02BA03 [21602449]

—

-1.0e+50

—

5.7e-01

—

cases:0.00%

controls:0.95%

—

cases:5.56%

controls:3.22%

—

941

—

872

Bacteria identified in Stool by Culture
625-4 [3025941]

—

-1.0e+50

—

cases:0.00%

controls:0.89%

—

893

Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]

7.3e-01

1.0e+00

—

5.7e-01

8.8e-01

cases:7.37%

controls:3.68%

cases:5.26%

controls:2.00%

—

cases:5.32%

controls:3.08%

cases:17.78%

controls:8.21%

915

931

—

914

827

sumatriptan; nasal, oral, parenteral, rectal
N02CC01 [21604376]

—

5.3e-01

—

cases:5.56%

controls:3.33%

—

871

Nonallergic asthma
J45.1 [45557625]

—

-1.0e+50

—

cases:0.00%

controls:1.11%

—

891

Diabetes mellitus screening
171183004 [4064918]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Ultrasound examination of paranasal sinuses
SPAT1028 [2001700129]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Choriogonadotropin [Units/volume] in Serum or Plasma
19080-1 [3018171]

—

-1.0e+50

—

cases:0.00%

controls:1.00%

—

892

Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.53%

—

cases:0.00%

controls:0.55%

945

—

896

Methadone [Presence] in Urine by Screen method
19550-3 [3028707]

-1.0e+50

—

cases:0.00%

controls:0.63%

—

944

—

fluticasone furoate; nasal
R01AD12 [21605053]

8.0e-01

1.2e+00

—

-1.0e+50

—

6.2e-01

cases:12.63%

controls:6.11%

cases:6.32%

controls:1.89%

—

cases:0.00%

controls:0.63%

—

cases:12.22%

controls:6.99%

892

932

—

944

—

838

Other and unspecified ovarian cysts
N83.2 [45539066]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

938

—

Abdominal pain/cramps general
D01 [2002000300]

—

-1.0e+50

—

cases:0.00%

controls:1.11%

—

891

diclofenac
D11AX18 [21602355]

—

-1.0e+50

1.6e+00

—

cases:0.00%

controls:1.06%

cases:6.67%

controls:1.44%

—

933

888

Albumin [Presence] in Urine by Test strip
50949-7 [3029937]

—

6.0e-01

—

cases:6.67%

controls:3.77%

—

867

Specific gravity of Urine by Refractometry
5810-7 [3019150]

—

4.7e-01

—

cases:5.56%

controls:3.55%

—

869

calcipotriol; ointment
D05AX02 [21602039]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

Respiratory and circulatory monitoring
WX700 [2001310817]

—

-1.0e+50

—

cases:0.00%

controls:0.74%

—

943

—

Hand and fingers X-ray examination
ND2AA [2001307607]

-1.0e+50

—

cases:0.00%

controls:0.63%

—

944

—

Norclozapine [Moles/volume] in Serum or Plasma
14851-0 [3008832]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Mucopurulent conjunctivitis
H10.0 [45596007]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Tension-type headache
G44.2 [45581495]

-1.0e+50

—

cases:0.00%

controls:0.74%

—

943

—

ethinylestradiol; oral
G03CA01 [21602516]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

cases:0.00%

controls:0.78%

—

945

—

894

prednisolone; oral, parenteral
H02AB06 [21602734]

9.3e-01

1.2e+00

—

7.8e-01

cases:10.53%

controls:4.42%

cases:6.32%

controls:2.00%

—

cases:14.44%

controls:7.21%

908

931

—

836

Maternal care for excessive fetal growth
O36.6 [45543983]

—

-1.0e+50

—

cases:0.00%

controls:0.78%

—

894

Restoration involving the entire crown of the tooth
SFA40 [2001310361]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:1.05%

—

cases:0.00%

controls:0.53%

cases:0.00%

controls:1.33%

940

—

938

889

Sleep apnoea
G47.3 [45562094]

—

1.4e+00

—

cases:5.56%

controls:1.44%

—

888

Monocytes/Leukocytes in Blood
26485-3 [3019069]

—

1.0e+00

9.2e-01

—

cases:5.32%

controls:2.01%

cases:13.33%

controls:5.77%

—

924

849

Remowal of suture of skin
TQW40 [2001310146]

—

-1.0e+50

—

cases:0.00%

controls:0.67%

—

895

Asthma
J45 [45596282]

—

9.5e-01

—

cases:5.56%

controls:2.22%

—

881

Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]

—

1.0e+00

—

cases:7.78%

controls:2.89%

—

875

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
O24.0 [45558213]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.63%

cases:0.00%

controls:0.53%

—

cases:0.00%

controls:1.44%

944

945

—

888

zopiclone; oral
N05CF01 [21604654]

7.7e-01

6.0e-01

—

6.8e-01

1.0e+00

cases:9.47%

controls:4.63%

cases:5.26%

controls:2.95%

—

cases:5.32%

controls:2.76%

cases:12.22%

controls:4.88%

906

922

—

917

857

other antifungals for topical use - combinations; ointment
D01AE20 [21601959]

—

-1.0e+50

—

cases:0.00%

controls:0.64%

—

937

—

hydroxocobalamin
V03AB33 [21605256]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.74%

—

cases:0.00%

controls:0.64%

—

943

—

937

—

glimepiride; oral
A10BB12 [21600761]

—

-1.0e+50

—

cases:0.00%

controls:0.64%

cases:0.00%

controls:1.00%

—

937

892

Kolposcopy
ULA02 [2001306679]

-1.0e+50

—

cases:0.00%

controls:0.95%

—

941

—

nifedipine; oral, parenteral
C08CA05 [21601751]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Laceration/cut
S18 [2002000983]

—

-1.0e+50

—

cases:0.00%

controls:1.05%

—

940

—

Cholesterol non HDL [Moles/volume] in Serum or Plasma
70204-3 [42868678]

—

-1.0e+50

—

cases:0.00%

controls:0.67%

—

895

fluoxetine; oral
N06AB03 [21604711]

9.0e-01

—

cases:5.26%

controls:2.21%

—

929

—

hydrocortisone
D07AA02 [21602102]

-2.5e-01

-1.0e+50

—

4.1e-01

cases:5.26%

controls:6.63%

cases:0.00%

controls:1.37%

—

cases:8.89%

controls:6.10%

887

937

—

846

hydrocortisone and antiseptics
D07BA04 [21602146]

—

-1.0e+50

—

cases:0.00%

controls:0.64%

—

937

—

Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

estradiol; nasal, oral, parenteral, rectal, transdermal, vaginal
G03CA03 [21602517]

3.5e-01

6.3e-01

—

5.2e-01

3.9e-01

cases:8.42%

controls:6.11%

cases:9.47%

controls:5.26%

—

cases:9.57%

controls:5.94%

cases:16.67%

controls:11.88%

892

900

—

887

107

794

Diabetes insulin dependent
T89 [2002001130]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.84%

cases:0.00%

controls:0.53%

—

cases:0.00%

controls:0.85%

cases:0.00%

controls:1.55%

942

945

—

935

887

Hystero-salpingography with ultrasound
LC2HE [2001306546]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Noninvasive ventilation
WX725 [2001310828]

—

-1.0e+50

—

cases:0.00%

controls:0.78%

—

894

Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]

3.0e-01

-2.7e-02

1.5e+00

—

6.6e-01

1.8e-01

cases:11.58%

controls:8.84%

cases:8.42%

controls:8.63%

cases:5.26%

controls:1.26%

—

cases:15.96%

controls:8.91%

cases:24.44%

controls:21.20%

866

868

938

—

859

191

710

Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]

-1.0e+50

—

cases:0.00%

controls:0.74%

—

943

—

phenoxymethylpenicillin; oral
J01CE02 [21602842]

8.6e-01

3.2e-01

—

-1.0e+50

1.1e+00

4.8e-01

cases:24.21%

controls:11.89%

cases:5.26%

controls:3.89%

—

cases:0.00%

controls:0.53%

cases:9.57%

controls:3.50%

cases:16.67%

controls:10.99%

113

837

913

—

945

910

802

Acute apical periodontitis of pulpal origin
K04.4 [45567286]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.53%

—

cases:0.00%

controls:0.89%

945

—

893

Chest pain NOS
A11 [2002000152]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Intubation
WX704 [2001310820]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Embedded teeth
K01.0 [45548133]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

sulfasalazine; oral, rectal
A07EC01 [21600663]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.63%

cases:0.00%

controls:0.53%

—

cases:0.00%

controls:0.64%

cases:0.00%

controls:1.00%

944

945

—

937

892

enoxaparin; parenteral
B01AB05 [21600976]

—

-1.0e+50

—

cases:0.00%

controls:0.84%

—

942

—

candesartan and diuretics
C09DA06 [21601838]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.95%

cases:0.00%

controls:0.63%

—

cases:0.00%

controls:0.53%

cases:0.00%

controls:1.66%

941

944

—

938

886

Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
49891-5 [3029511]

—

-1.0e+50

—

cases:0.00%

controls:0.78%

—

894

Foot/toe symptom/complaint
L17 [2002000641]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.68%

—

cases:0.00%

controls:0.64%

—

934

—

937

—

Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]

—

4.9e-01

—

cases:8.89%

controls:5.66%

—

850

timolol
S01ED01 [21603699]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.05%

—

cases:0.00%

controls:0.95%

cases:0.00%

controls:1.00%

—

940

—

934

892

Sampling
SPAT1263 [2001700364]

—

5.6e-02

—

cases:6.67%

controls:6.33%

—

844

Anxiety disorder/anxiety state
P74 [2002000868]

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

cetirizine; oral
R06AE07 [21603497]

2.7e-01

—

8.0e-01

3.8e-01

cases:9.47%

controls:7.37%

—

cases:6.38%

controls:2.97%

cases:11.11%

controls:7.88%

880

—

915

830

Stomach Pathology biopsy report
66114-0 [40768797]

-1.0e+50

—

cases:0.00%

controls:0.74%

cases:0.00%

controls:0.53%

—

943

945

—

fluvoxamine; oral
N06AB08 [21604716]

—

-1.0e+50

—

cases:0.00%

controls:0.67%

—

895

Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

938

—

oseltamivir; oral
J05AH02 [21603179]

—

-1.0e+50

—

cases:0.00%

controls:0.67%

—

895

Contusion of lower back and pelvis
S30.0 [45549279]

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

escitalopram; oral
N06AB10 [21604718]

6.0e-01

—

cases:5.26%

controls:2.95%

—

922

—

Coloscopy
UJF32 [2001305029]

—

-1.0e+50

—

cases:0.00%

controls:1.11%

—

891

medroxyprogesterone and estradiol
G03AA17 [715900]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]

-8.1e-02

—

4.6e-01

2.1e-01

cases:5.26%

controls:5.68%

—

cases:6.38%

controls:4.14%

cases:14.44%

controls:11.99%

896

—

904

108

793

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2500B [2000402295]

-1.0e+50

—

cases:0.00%

controls:1.79%

—

933

—

Removal of cutom molded cast and internal stretch
TNX50 [2001308568]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Pain in limb
M79.6 [45587063]

—

-1.0e+50

1.1e+00

—

cases:0.00%

controls:0.64%

cases:8.89%

controls:3.11%

—

937

873

Headache
R51 [45558474]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.53%

—

cases:0.00%

controls:0.55%

945

—

896

losartan; oral
C09CA01 [21601824]

-1.0e+50

—

cases:0.00%

controls:1.68%

cases:0.00%

controls:1.05%

—

934

940

—

Ankle symptom/complaint
L16 [2002000640]

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

Caries of dentine
K02.1 [45548134]

7.1e-01

—

-1.0e+50

—

-1.0e+50

5.4e-01

5.9e-01

cases:12.63%

controls:6.63%

—

cases:0.00%

controls:0.84%

—

cases:0.00%

controls:0.74%

cases:5.32%

controls:3.18%

cases:18.89%

controls:11.43%

887

—

942

—

943

913

103

798

orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]

1.8e-01

—

2.4e-01

cases:5.26%

controls:4.42%

—

cases:6.67%

controls:5.33%

908

—

853

valsartan and diuretics
C09DA03 [21601836]

—

-1.0e+50

—

cases:0.00%

controls:0.67%

—

895

ferrous glycine sulfate; oral
B03AA01 [21601080]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Specific gravity of Urine by Test strip
5811-5 [3000330]

—

-1.0e+50

—

cases:0.00%

controls:1.33%

—

889

Emergency Room and Inpatient Visit
ERIP [262]

—

-1.0e+50

8.1e-01

—

cases:0.00%

controls:0.53%

cases:5.56%

controls:2.55%

—

938

878

Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]

—

9.0e-01

—

cases:5.56%

controls:2.33%

—

880

Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]

—

1.2e+00

1.1e-01

—

cases:5.32%

controls:1.59%

cases:5.56%

controls:4.99%

—

928

856

Examination for recruitment to armed forces
Z02.3 [45576125]

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

Psychosocial counselling and guidance
SPAT1307 [2001700408]

-1.0e+50

—

cases:0.00%

controls:0.95%

—

941

—

latanoprost
S01EE01 [21603710]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.95%

cases:0.00%

controls:0.74%

—

cases:0.00%

controls:0.64%

—

941

943

—

937

—

Besnier prurigo
L20.0 [45562534]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.53%

—

cases:0.00%

controls:0.89%

945

—

893

Unspecified nonorganic psychosis
F29 [45533099]

-1.0e+50

—

cases:0.00%

controls:0.84%

cases:0.00%

controls:0.53%

—

942

945

—

Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]

-1.0e+50

—

cases:0.00%

controls:0.74%

—

943

—

Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]

—

5.3e-01

—

cases:8.89%

controls:5.44%

—

852

Gynaecological examination (general)(routine)
Z01.4 [45542395]

-1.0e+50

—

cases:0.00%

controls:0.84%

—

942

—

bisoprolol; oral
C07AB07 [21601689]

4.0e-01

1.3e-01

—

2.4e-01

6.7e-01

cases:7.37%

controls:5.05%

cases:5.26%

controls:4.63%

—

cases:5.32%

controls:4.24%

cases:13.33%

controls:7.33%

902

906

—

903

835

Recording of ECG
SPAT1097 [2001700198]

—

-1.0e+50

—

cases:0.00%

controls:1.00%

—

892

Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]

1.1e-01

—

6.8e-01

6.5e-01

cases:5.26%

controls:4.74%

—

cases:5.32%

controls:2.76%

cases:17.78%

controls:10.10%

905

—

917

810

Albumin [Mass/volume] in Urine
1754-1 [3012516]

-1.0e+50

—

cases:0.00%

controls:1.58%

cases:0.00%

controls:1.58%

—

935

—

Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]

4.8e-01

1.9e-01

—

6.3e-01

2.9e-01

cases:11.58%

controls:7.47%

cases:8.42%

controls:7.05%

—

cases:12.77%

controls:7.21%

cases:23.33%

controls:18.53%

879

883

—

875

167

734

digoxin; oral, parenteral
C01AA05 [21600234]

—

-1.0e+50

—

cases:0.00%

controls:0.63%

—

944

—

diclofenac, combinations; oral
M01AB55 [21603959]

-1.0e+50

—

cases:0.00%

controls:0.63%

—

944

—

Hysteroscopic excision of lesion
LCB25 [2001306568]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

dalteparin; parenteral
B01AB04 [21600975]

—

-1.0e+50

—

cases:0.00%

controls:0.78%

—

894

levocabastine
S01GX02 [21605086]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.84%

—

cases:0.00%

controls:0.67%

942

—

895

Person consulting for explanation of investigation findings
Z71.2 [45552100]

—

-1.0e+50

—

cases:0.00%

controls:0.64%

—

937

—

Midwife
Z3232 [2001311563]

—

-1.0e+50

—

cases:0.00%

controls:1.11%

—

891

Visit based on need for special support
SPAT1389 [2001700489]

-1.0e+50

—

cases:0.00%

controls:0.63%

—

944

—

azelaic acid; ointment
D10AX03 [21602314]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.53%

—

cases:0.00%

controls:0.78%

945

—

894

FEV1/FVC --post bronchodilation
69970-2 [42868459]

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

Severe psychotic and other severe mental disorders
112 [2001600112]

—

2.2e+00

—

cases:5.56%

controls:0.67%

—

895

Other reactions to severe stress
F43.8 [45552483]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

ABO and Rh group [Type] in Blood
882-1 [3003694]

1.8e+00

—

cases:6.32%

controls:1.05%

—

940

—

MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]

2.7e-01

1.4e-01

1.5e+00

—

3.6e-01

1.1e-01

cases:13.68%

controls:10.84%

cases:12.63%

controls:11.16%

cases:7.37%

controls:1.68%

—

cases:14.89%

controls:10.92%

cases:27.78%

controls:25.64%

103

847

106

844

934

—

103

840

231

670

INR in Blood by Coagulation assay
34714-6 [3032080]

-1.0e+50

—

1.8e+00

1.1e+00

cases:0.00%

controls:1.37%

—

cases:5.32%

controls:0.95%

cases:8.89%

controls:3.00%

937

—

934

874

ciprofloxacin; oral, parenteral
J01MA02 [21603009]

7.3e-01

—

5.1e-01

cases:6.32%

controls:3.16%

—

cases:6.67%

controls:4.11%

920

—

864

Deposits [accretions] on teeth betel
K03.65 [2000502690]

—

-1.0e+50

—

cases:0.00%

controls:0.85%

—

935

—

Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

nedocromil; inhalant
R03BC03 [21603299]

-1.0e+50

—

cases:0.00%

controls:0.74%

—

943

—

Skin symptom/complaint other
S29 [2002000993]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

levonorgestrel
G03AC03 [21602499]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.63%

—

cases:0.00%

controls:0.64%

—

944

—

937

—

diazepam; oral, parenteral, rectal
N05BA01 [21604566]

1.4e+00

—

cases:6.32%

controls:1.68%

—

934

—

cloZAPine [Moles/volume] in Serum or Plasma
14656-3 [3000081]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Diabetes, non-insulin-treated
215 [2001600211]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.95%

—

cases:0.00%

controls:0.64%

cases:0.00%

controls:2.44%

941

—

937

879

Small restoration
SFA00 [2001310357]

—

-1.0e+50

—

cases:0.00%

controls:0.78%

—

894

tenoxicam; oral, parenteral, rectal
M01AC02 [21603962]

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]

-3.6e-01

1.6e-01

—

2.4e-01

8.6e-03

cases:5.26%

controls:7.37%

cases:8.42%

controls:7.26%

—

cases:7.45%

controls:5.94%

cases:18.89%

controls:18.76%

880

881

—

887

169

732

Counselling, unspecified
Z71.9 [45561648]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

tiaprofenic acid; oral, rectal
M01AE11 [21603977]

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

betamethasone
C05AA05 [21601610]

5.5e-01

—

4.4e-01

cases:8.42%

controls:5.05%

—

cases:8.89%

controls:5.88%

902

—

848

fenoterol and ipratropium bromide
R03AL01 [43534843]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.53%

—

cases:0.00%

controls:0.55%

945

—

896

ezetimibe; oral
C10AX09 [21601896]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

cases:0.00%

controls:0.53%

—

945

—

938

—

Supplier / Service Provider
OMOP5117446 [33004]

-1.2e+00

—

1.0e+50

—

cases:7.37%

controls:20.32%

—

cases:6.38%

controls:0.00%

—

193

757

—

943

—

Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]

1.0e+00

1.6e+00

—

2.9e-01

cases:6.32%

controls:2.32%

cases:5.26%

controls:1.16%

—

cases:8.89%

controls:6.77%

928

939

—

840

Routine postpartum follow-up
Z39.2 [45547306]

—

-1.0e+50

—

cases:0.00%

controls:1.89%

—

884

Chronic apical periodontitis
K04.5 [45586691]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.84%

—

cases:0.00%

controls:0.74%

—

942

—

936

—

lovastatin; oral
C10AA02 [21601857]

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

semaglutide; oral, parenteral
A10BJ06 [1501778]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

cases:0.00%

controls:0.53%

cases:0.00%

controls:0.55%

—

945

—

938

896

Normoblasts [#/volume] in Blood
715-3 [3021589]

—

5.9e-01

—

cases:8.89%

controls:5.11%

—

855

Pediatric Medicine
37 [38004477]

—

-1.0e+50

—

cases:0.00%

controls:1.06%

cases:0.00%

controls:1.44%

—

933

888

Aortic (valve) stenosis
I35.0 [45576869]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Vaccination
SPAT1325 [2001700426]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.74%

—

cases:0.00%

controls:0.85%

—

943

—

935

—

Exhaustion due to excessive exertion
T73.3 [45556213]

—

1.0e+50

—

cases:75.79%

controls:0.00%

cases:7.37%

controls:0.00%

cases:8.51%

controls:0.00%

—

950

943

—

Arthrosis, unspecified
M19.9 [45543488]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Overexertion and strenuous or repetitive movements
X50 [45756406]

—

1.0e+50

—

cases:8.42%

controls:0.00%

—

950

—

Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]

—

-1.0e+50

—

cases:0.00%

controls:0.64%

—

937

—

Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]

—

9.2e-01

8.4e-01

—

cases:6.38%

controls:2.65%

cases:14.44%

controls:6.77%

—

918

840

Infiltration anesthesia
WX110 [2001310767]

6.4e-01

—

-1.0e+50

—

7.1e-01

6.3e-01

cases:13.68%

controls:7.68%

—

cases:0.00%

controls:0.95%

—

cases:7.45%

controls:3.82%

cases:18.89%

controls:10.99%

877

—

941

—

907

802

Ophthalmology
18 [38004463]

-3.5e-01

—

-1.0e+50

—

-3.2e-02

cases:6.32%

controls:8.74%

—

cases:0.00%

controls:0.84%

—

cases:11.11%

controls:11.43%

867

—

942

—

103

798

carvedilol; oral
C07AG02 [21601700]

-1.0e+50

—

cases:0.00%

controls:0.53%

cases:0.00%

controls:0.74%

—

945

943

—

Moderate depressive episode
F32.1 [45552478]

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

Ketones [Presence] in Urine by Test strip
2514-8 [3035350]

9.5e-01

1.4e+00

—

4.4e-01

cases:6.32%

controls:2.53%

cases:6.32%

controls:1.58%

—

cases:11.11%

controls:7.44%

926

935

—

834

Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]

-1.0e+50

—

cases:0.00%

controls:0.63%

cases:0.00%

controls:0.84%

—

944

942

—

Laparoscopic unilateral salpingo-oophorectomy
LAF01 [2001306442]

—

-1.0e+50

—

cases:0.00%

controls:0.67%

—

895

Dental impressions
SBB10 [2001310299]

—

-1.0e+50

—

cases:0.00%

controls:0.67%

—

895

Extraction of tooth
EBA00 [2001301923]

-1.0e+50

—

cases:0.00%

controls:3.58%

cases:0.00%

controls:1.26%

—

916

938

—

Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]

—

4.3e-01

—

cases:6.67%

controls:4.44%

—

861

Left side
ZXA05 [2001311347]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

Other and unspecified abdominal pain
R10.4 [45568113]

4.7e-01

—

7.3e-01

cases:5.26%

controls:3.37%

—

cases:11.11%

controls:5.66%

918

—

850

erdosteine; oral
R05CB15 [21603394]

—

-1.0e+50

—

cases:0.00%

controls:0.64%

—

937

—

Lumbar epidural anesthesia
WX306 [2001310796]

-1.0e+50

—

cases:0.00%

controls:0.74%

—

943

—

Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]

—

1.5e+00

—

cases:6.67%

controls:1.55%

—

887

naproxcinod
M01AE18 [40254094]

6.1e-01

7.6e-01

—

6.8e-01

cases:17.89%

controls:10.63%

cases:6.32%

controls:3.05%

—

cases:14.44%

controls:7.88%

101

849

921

—

830

hypromellose
S01KA02 [21605115]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:1.05%

—

cases:0.00%

controls:0.64%

—

940

—

937

—

orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]

1.8e-01

—

2.4e-01

cases:5.26%

controls:4.42%

—

cases:6.67%

controls:5.33%

908

—

853

FVC percent change Respiratory system
69982-7 [42868471]

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

Albumin/Creatinine [Ratio] in Urine
32294-1 [3020682]

-1.0e+50

—

cases:0.00%

controls:1.79%

cases:0.00%

controls:1.58%

—

933

935

—

piroxicam; ointment
M02AA07 [21604043]

—

1.8e+00

—

cases:5.26%

controls:0.95%

—

941

—

General counselling and advice on contraception
Z30.0 [45537624]

—

-1.0e+50

—

cases:0.00%

controls:0.67%

—

895

chloramphenicol
S01AA01 [21603554]

5.3e-01

—

1.1e+00

7.4e-01

cases:5.26%

controls:3.16%

—

cases:5.32%

controls:1.80%

cases:8.89%

controls:4.44%

920

—

926

861

Polyp of cervix uteri
N84.1 [45567867]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Other fall from one level to another
W17 [45756255]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

insulin (beef); parenteral
A10AD02 [21600730]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:2.84%

cases:0.00%

controls:2.74%

cases:0.00%

controls:0.63%

—

cases:0.00%

controls:0.63%

cases:0.00%

controls:2.76%

—

923

924

944

—

944

917

—

Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
12841-3 [3001784]

—

1.7e+00

—

cases:5.32%

controls:1.06%

—

933

—

Health check-up performed during first study year in students of upper secondary schools, vocational schools etc.
SPAT1363 [2001700464]

-1.0e+50

—

cases:0.00%

controls:0.95%

—

941

—

atorvastatin; oral
C10AA05 [21601860]

—

1.5e-01

—

cases:6.67%

controls:5.77%

—

849

Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21613-5 [3006093]

-1.0e+50

—

cases:0.00%

controls:0.74%

—

943

—

Limited function/disability (L)
L28 [2002000647]

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.63%

—

cases:0.00%

controls:0.67%

944

—

895

Periodontitis NOS
K05.32 [2000502730]

—

-1.0e+50

—

cases:0.00%

controls:0.89%

—

893

venlafaxine; oral
N06AX16 [21604745]

—

1.1e+00

—

cases:7.78%

controls:2.77%

—

876

Bacteria identified in Skin by Aerobe culture
620-5 [3007853]

—

-1.0e+50

—

cases:0.00%

controls:0.63%

—

944

—

Assistance to normal delivery
MAX99 [2001306918]

—

-1.0e+50

—

cases:0.00%

controls:1.33%

—

889

loratadine; oral
R06AX13 [21603514]

—

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.63%

—

cases:0.00%

controls:0.74%

—

944

—

936

—

fluticasone; inhalant
R03BA05 [21603288]

—

-1.0e+50

—

cases:0.00%

controls:1.91%

—

925

—

amphotericin B; oral
A07AA07 [21600609]

-1.0e+50

—

cases:0.00%

controls:0.84%

—

942

—

Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]

—

5.9e-01

—

cases:8.89%

controls:5.11%

—

855

atenolol; oral, parenteral
C07AB03 [21601685]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.74%

cases:0.00%

controls:0.53%

—

cases:0.00%

controls:0.64%

cases:0.00%

controls:0.67%

943

945

—

937

895

Other function in accordance with SHToL (Finnish classification of nursing interventions)
SPAT1292 [2001700393]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

brompheniramine, combinations
R06AB51 [21603466]

5.3e-01

—

6.6e-01

cases:5.26%

controls:3.16%

—

cases:6.67%

controls:3.55%

920

—

869

Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:0.84%

cases:0.00%

controls:0.53%

—

cases:0.00%

controls:1.17%

—

942

945

—

932

—

Periodontal treatment by dental hygienist
SDE02 [2001310350]

—

-1.0e+50

—

cases:0.00%

controls:0.63%

—

944

—

Type 2 diabetes mellitus, without complications
E11.9 [45561952]

—

-1.0e+50

—

cases:0.00%

controls:0.74%

—

936

—

Asthma
R96 [2002000961]

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

Plugged feeling ear
H13 [2002000480]

-1.0e+50

—

cases:0.00%

controls:0.63%

—

944

—

Social phobias
F40.1 [45595907]

—

-1.0e+50

—

cases:0.00%

controls:0.67%

—

895

SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: never
SMOKING-2-3-5 [2002330114]

—

-1.0e+50

—

cases:0.00%

controls:1.58%

—

935

—

pseudoephedrine, combinations; oral
R01BA52 [21603213]

3.1e-01

1.0e+00

—

3.2e-01

cases:13.68%

controls:10.42%

cases:8.42%

controls:3.16%

—

cases:14.44%

controls:10.88%

851

920

—

803

MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]

2.7e-01

3.8e-01

1.6e+00

—

6.2e-01

2.7e-01

cases:10.53%

controls:8.21%

cases:11.58%

controls:8.21%

cases:6.32%

controls:1.37%

—

cases:12.77%

controls:7.32%

cases:24.44%

controls:19.76%

872

937

—

874

178

723

Sterilization
Z30.2 [45609921]

—

-1.0e+50

—

cases:0.00%

controls:0.78%

—

894

hydrocortisone butyrate
D07AB02 [21602106]

-2.5e-01

-1.0e+50

—

4.1e-01

cases:5.26%

controls:6.63%

cases:0.00%

controls:1.37%

—

cases:8.89%

controls:6.10%

887

937

—

846

Audiology
64 [38004489]

—

-1.0e+50

—

cases:0.00%

controls:0.89%

—

893

trimipramine; oral, parenteral
N06AA06 [21604693]

—

-1.0e+50

—

cases:0.00%

controls:0.67%

—

895

Routine general health check-up of other defined subpopulations
Z10.8 [45609907]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

hydrocortisone
C05AA01 [21601608]

-2.6e-01

—

4.1e-01

cases:5.26%

controls:6.74%

—

cases:8.89%

controls:6.10%

886

—

846

prednisolone
A07EA01 [21600653]

9.3e-01

1.2e+00

—

7.8e-01

cases:10.53%

controls:4.42%

cases:6.32%

controls:2.00%

—

cases:14.44%

controls:7.21%

908

931

—

836

Intestinal infections due to other organisms, Other organism, not elsewhere classified
0088X [2000400186]

-1.0e+50

—

cases:0.00%

controls:0.63%

—

944

—

Leukocytes [#/volume] in Urine
30405-5 [3018095]

—

1.3e+00

—

cases:11.11%

controls:3.33%

—

871

Other psychiatric treatment contact
IGY99 [2001304323]

—

-1.0e+50

—

cases:0.00%

controls:0.67%

—

895

Pain in thoracic spine
M54.6 [45606247]

—

-1.0e+50

—

cases:0.00%

controls:0.67%

—

895

Pulmonary Disease
29 [38004472]

4.9e-01

—

1.5e+00

1.1e+00

cases:7.37%

controls:4.63%

—

cases:8.51%

controls:2.01%

cases:12.22%

controls:4.55%

906

—

924

860

Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]

—

-1.0e+50

—

1.5e+00

6.9e-01

—

cases:0.00%

controls:0.95%

—

cases:5.32%

controls:1.27%

cases:6.67%

controls:3.44%

—

941

—

931

870

azithromycin; oral, parenteral
J01FA10 [21602978]

2.4e-01

—

3.9e-01

cases:11.58%

controls:9.37%

—

cases:13.33%

controls:9.43%

861

—

816

General examination of pregnant woman
XMA22 [2001306916]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.63%

—

cases:0.00%

controls:1.00%

944

—

892

Lymphocytes/Leukocytes in Blood
26478-8 [3002030]

—

9.5e-01

8.6e-01

—

cases:5.32%

controls:2.12%

cases:14.44%

controls:6.66%

—

923

841

Supervision of normal pregnancy
Z34 [45566419]

-1.0e+50

—

cases:0.00%

controls:0.95%

—

941

—

Basophils/Leukocytes in Blood
30180-4 [3022096]

—

1.0e+00

8.8e-01

—

cases:5.32%

controls:2.01%

cases:13.33%

controls:5.99%

—

924

847

prednisone
A07EA03 [21600655]

—

-1.0e+50

—

cases:0.00%

controls:1.00%

—

892

Biopsy of endometrium
LCA06 [2001306551]

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

Pregnancy, Medical examin/health eval partial
W31 [2002001224]

-1.0e+50

—

cases:0.00%

controls:0.53%

—

945

—

Nuclear Ab [Titer] in Serum
29953-7 [3037522]

-1.0e+50

—

cases:0.00%

controls:0.63%

—

944

—

losartan and diuretics
C09DA01 [21601834]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:1.16%

cases:0.00%

controls:0.74%

—

cases:0.00%

controls:0.74%

cases:0.00%

controls:1.33%

939

943

—

936

889

Dental examination
Z01.2 [45581002]

7.2e-01

—

5.9e-01

cases:5.26%

controls:2.63%

—

cases:10.00%

controls:5.77%

925

—

849

Obstetrics / Gynecology
16 [38004461]

4.8e-01

7.4e-01

—

3.4e-03

3.8e-01

cases:24.21%

controls:16.53%

cases:11.58%

controls:5.89%

—

cases:7.45%

controls:7.42%

cases:25.56%

controls:18.98%

157

793

894

—

873

171

730

Depressive disorder
P76 [2002000870]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:1.16%

—

cases:0.00%

controls:0.67%

939

—

895

Personal history of diseases of the digestive system
Z87.1 [45542474]

6.8e-01

—

cases:5.26%

controls:2.74%

—

924

—

Counselling and guidance which enhance independent living
R2130 [2001310196]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.63%

—

cases:0.00%

controls:1.00%

944

—

892

fusidic acid; ointment
D06AX01 [21602062]

—

9.5e-01

—

cases:5.56%

controls:2.22%

—

881

glyceryl trinitrate; local oral, oral, sublingual, transdermal
C01DA02 [21600317]

—

1.3e+00

—

cases:6.67%

controls:2.00%

—

883

Three-surface restoration
SFA30 [2001310360]

—

-1.0e+50

—

1.4e-01

—

cases:0.00%

controls:0.53%

—

cases:5.56%

controls:4.88%

—

945

—

857

Presence of intraocular lens
Z96.1 [45585885]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:0.84%

—

cases:0.00%

controls:1.00%

942

—

892

metoprolol; oral, parenteral
C07AB02 [21601684]

—

9.7e-01

—

cases:7.78%

controls:3.11%

—

873

insulin glargine; parenteral
A10AE04 [21600739]

-1.0e+50

—

-1.0e+50

—

cases:0.00%

controls:2.84%

cases:0.00%

controls:2.74%

cases:0.00%

controls:0.63%

—

cases:0.00%

controls:0.63%

cases:0.00%

controls:2.76%

—

923

924

944

—

944

917

—

Counselling and guidance related to nutrition and weight management
SPAT1306 [2001700407]

—

-1.0e+50

—

cases:0.00%

controls:1.22%

—

890

flumetasone and antiinfectives
S02CA02 [21605174]

-1.0e+50

—

-1.0e+50

cases:0.00%

controls:1.37%

—

cases:0.00%

controls:0.55%

937

—

896

Other specified medical care
Z51.88 [2000503765]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Intramuscular and subcutaneous injection
SPAT1256 [2001700357]

—

-1.0e+50

—

cases:0.00%

controls:0.53%

cases:0.00%

controls:1.59%

—

945

928

—

Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]

4.8e-01

—

7.9e-01

2.8e-01

cases:6.32%

controls:4.00%

—

cases:8.51%

controls:4.03%

cases:13.33%

controls:10.43%

912

—

905

807

Throat symptom/complaint
R21 [2002000891]

—

-1.0e+50

—

cases:0.00%

controls:0.74%

—

936

—

Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]

—

1.2e+00

1.0e+00

—

cases:5.32%

controls:1.59%

cases:11.11%

controls:4.22%

—

928

863

diclofenac; oral, parenteral, rectal
M01AB05 [21603945]

1.8e-01

2.9e-01

—

6.0e-01

cases:13.68%

controls:11.68%

cases:5.26%

controls:4.00%

—

cases:21.11%

controls:12.76%

111

839

912

—

115

786

Simple examination of mouth
SAA01 [2001310274]

2.2e-01

1.3e-01

—

9.2e-01

2.9e-01

cases:11.58%

controls:9.47%

cases:5.26%

controls:4.63%

—

cases:9.57%

controls:4.03%

cases:18.89%

controls:14.87%

860

906

—

905

134

767

Lactate [Moles/volume] in Venous blood
2519-7 [3008037]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Delivery by emergency caesarean section
O82.10 [2000503217]

-1.0e+50

—

cases:0.00%

controls:1.16%

—

939

—

ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]

-2.1e-01

—

cases:6.32%

controls:7.68%

—

877

—

SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]

—

2.8e-01

—

cases:12.22%

controls:9.54%

—

815

sertraline; oral
N06AB06 [21604714]

-1.0e+50

—

cases:0.00%

controls:1.58%

—

935

—

Depressive episode, unspecified
F32.9 [45571760]

—

1.3e+00

—

cases:7.78%

controls:2.33%

—

880

Cough
R05 [45606792]

-1.0e+50

—

cases:0.00%

controls:0.84%

—

942

—

travoprost
S01EE04 [21603713]

—

-1.0e+50

—

cases:0.00%

controls:0.55%

—

896

Insertion of (intrauterine) contraceptive device
Z30.1 [45537626]

—

1.6e+00

—

cases:5.56%

controls:1.22%

—

890

pimecrolimus
D11AH02 [21602339]

—

-1.0e+50

—

cases:0.00%

controls:0.78%

—

894

Short blood count panel - Blood
55429-5 [40758558]

—

9.6e-01

—

cases:6.67%

controls:2.66%

—

877

Case Management Agency
251B00000X [38004193]

3.4e-01

3.6e-01

4.4e-01

—

7.0e-01

1.6e-01

-3.4e-02

cases:40.00%

controls:32.11%

cases:32.63%

controls:25.26%

cases:13.68%

controls:9.26%

—

cases:16.84%

controls:9.16%

cases:29.79%

controls:26.62%

cases:45.56%

controls:46.39%

305

645

240

710

862

—

863

251

692

418

483

Dental caries
K02 [45552906]

—

-1.0e+50

—

cases:0.00%

controls:0.67%

—

895

almotriptan; oral
N02CC05 [21604380]

—

-1.0e+50

—

cases:0.00%

controls:0.78%

—

894

etoricoxib; oral
M01AH05 [21603996]

3.2e-01

—

4.0e-01

cases:7.37%

controls:5.47%

—

cases:12.22%

controls:8.55%

898

—

824

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

3.60

2.69

1.7

1.3

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

282

1.96

2.58

4.8

3.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

189

1.95

2.25

1.8

2.0

0.63

1.12

mg/l

1.19

139

(3027944) Amphetamines [Presence] in Urine

2.48

2.20

1.9

1.7

—

(3027008) Opiates [Presence] in Urine

2.48

2.20

1.9

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

2.48

2.20

1.9

1.7

—

(3028300) Cannabinoids [Presence] in Urine

2.48

2.20

1.9

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2.39

2.18

1.0

1.4

34.80

150.22

u/ml

—

(3003396) Base excess in Arterial blood by calculation

2.17

1.88

2.6

9.1

0.01

1.42

mmol/l

—

(3016879) Cocaine [Presence] in Urine

2.35

1.88

2.0

1.7

—

(3001604) Monocytes [#/volume] in Blood

430

1.74

1.84

6.8

6.2

0.59

0.57

e9/l

0.39

383

(3015377) Calcium [Moles/volume] in Serum or Plasma

273

1.73

1.77

8.3

3.3

2.35

mmol/l

0.11

247

(3019198) Lymphocytes [#/volume] in Blood

443

1.72

1.76

6.8

6.2

1.90

1.89

e9/l

0.01

403

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

1.76

0.0

1.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

338

1.70

1.74

9.0

5.3

37.64

36.57

g/l

0.56

328

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

166

1.78

1.60

1.5

1.3

0.90

8.48

u/ml

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

158

1.79

1.59

3.6

3.2

24.56

153.07

ng/l

1.63

110

(3006315) Basophils [#/volume] in Blood

431

1.66

1.58

6.9

6.2

0.05

0.04

e9/l

0.67

382

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.31

1.57

2.2

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

126

1.86

1.57

1.3

1.5

256.00

564.14

titre

—

(3011288) Drugs identified in Urine by Screen method Nominal

2.37

1.52

2.4

1.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

3.24

1.45

2.0

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

138

1.77

1.42

5.3

2.8

25.82

3.27

e6/l

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1.96

1.41

2.7

8.8

13.79

12.87

kpa

0.24

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1.96

1.41

2.7

8.8

4.78

5.07

kpa

0.87

(1002224) Polysomnography panel

2.26

1.39

1.2

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2.60

1.32

1.0

1.1

—

(40758558) Short blood count panel - Blood

236

1.61

1.32

10.8

7.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

295

1.55

1.22

3.4

3.1

17.67

35.88

ng/l

0.96

170

(42870588) Differential panel, method unspecified - Blood

286

1.55

1.21

6.7

5.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

205

1.60

1.21

2.2

4.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2.39

1.20

3.0

1.6

23.83

24.15

mmol/l

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2.39

1.20

2.7

1.6

0.20

0.24

g/l

—

(3022145) Colonoscopy Study observation

1.84

1.20

1.2

1.4

—

(3023368) Bacteria identified in Blood by Culture

215

1.58

1.18

3.4

4.4

—

(3021589) Normoblasts [#/volume] in Blood

363

1.52

1.18

8.1

10.9

0.00

0.01

e9/l

0.50

297

(3019150) Specific gravity of Urine by Refractometry

182

1.59

1.12

4.5

3.3

1.02

kg/l

0.38

114

(3000494) Fungus identified in Specimen by Culture

1.77

1.08

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

447

1.48

1.06

4.3

3.5

0.00

estimate

—

(4094501) Cardiovascular stress test using bicycle ergometer

2.34

1.04

1.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

324

1.47

1.01

4.4

3.4

0.00

estimate

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.02

0.99

1.3

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

145

1.58

0.95

2.0

2.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

225

1.49

0.95

1.3

1.4

0.70

1.36

u/ml

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

216

1.49

0.94

2.0

1.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

485

1.44

0.92

11.6

11.8

3.87

4.15

e9/l

0.54

435

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.81

0.90

1.4

2.0

—

(3002582) Erythrocytes [#/volume] in Urine

264

1.45

0.90

5.6

3.2

17.24

56.75

e6/l

0.88

198

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

130

1.58

0.90

1.8

2.1

—

(3030467) Casts [#/volume] in Urine by Automated count

228

1.46

0.88

4.5

3.1

0.08

0.28

e6/l

1.37

163

(3048689) Calprotectin [Mass/mass] in Stool

114

1.60

0.87

1.9

2.1

53.11

85.43

ug/g

—

(3028707) Methadone [Presence] in Urine by Screen method

1.93

0.83

3.0

1.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

562

1.43

0.83

6.1

4.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.87

0.80

1.0

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

454

1.38

0.78

4.4

3.5

0.00

16.92

estimate

—

(3022313) Gas panel - Capillary blood

1.81

0.77

1.8

3.4

—

(3009261) Glucose [Presence] in Urine by Test strip

455

1.37

0.76

4.4

3.5

0.00

estimate

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.66

0.76

1.5

2.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

201

0.64

0.75

1.6

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.81

0.73

1.4

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.81

0.73

1.1

1.5

—

(3000991) Gas panel - Venous blood

1.67

0.72

7.5

9.5

—

(3015736) pH of Urine

379

1.36

0.72

3.6

3.3

6.48

6.18

1.06

206

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

138

1.47

0.69

4.1

4.2

23.05

20.37

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.90

0.69

2.4

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.56

0.69

2.4

1.6

—

(3019060) Gas panel - Arterial blood

1.68

0.68

1.1

4.1

—

(3020891) Body temperature

1.83

0.67

1.4

3.2

37.02

37.00

°c

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

412

1.33

0.66

3.4

3.1

115.51

94.39

ug/l

0.53

391

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1.76

0.64

1.0

2.7

172.00

170.79

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

149

1.43

0.64

3.8

2.7

0.71

0.73

e6/l

—

(3018095) Leukocytes [#/volume] in Urine

307

1.34

0.64

6.4

3.9

36.90

162.30

e6/l

0.68

202

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

382

0.76

0.59

3.2

2.7

—

estimate

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1.76

0.59

2.5

2.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

244

1.34

0.58

4.6

3.1

0.00

estimate

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.62

0.55

1.3

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

100

0.57

0.55

1.5

—

(36304419) Bacteria [Presence] in Urine

218

1.33

0.55

5.0

3.0

—

estimate

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.53

0.53

2.4

3.6

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.45

0.53

1.7

1.3

—

(3025941) Bacteria identified in Stool by Culture

1.56

0.49

1.3

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.46

0.47

2.9

11.7

1.20

1.23

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.46

0.47

2.7

11.7

0.63

0.62

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.43

0.46

4.4

9.3

21.76

25.68

mmol/l

—

(3009508) Creatinine [Moles/volume] in Urine

252

1.28

0.46

3.7

3.4

6.74

8.05

mmol/l

0.90

220

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.39

0.42

1.7

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

217

1.27

0.41

1.5

1.4

2.60

2.35

g/l

0.32

133

(3018418) pH of Serum or Plasma

236

1.26

0.41

9.5

3.9

7.37

7.40

1.60

170

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.0

—

4.10

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.41

0.0

1.2

—

(3002256) Pathology report gross observation

1.38

0.40

1.2

1.3

—

(3032080) INR in Blood by Coagulation assay

316

1.22

0.37

15.0

13.9

1.19

1.21

inr

0.07

263

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.35

0.34

1.8

1.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.40

0.32

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

620

1.21

0.32

3.9

3.6

—

(3000492) Spirometry study

1.33

0.31

1.3

1.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

895

0.77

0.31

26.8

22.7

139.32

136.68

g/l

1.08

889

(3024731) MCV [Entitic mean volume] in Red Blood Cells

895

0.77

0.31

26.5

22.5

90.74

90.43

0.28

889

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

895

0.77

0.31

26.9

23.1

41.59

40.86

1.03

889

(3010813) Leukocytes [#/volume] in Blood

895

0.77

0.31

26.6

22.6

6.71

6.68

e9/l

0.07

880

(3026361) Erythrocytes [#/volume] in Blood

895

0.77

0.31

26.5

22.6

4.60

4.55

e12/l

0.41

880

(3035941) MCH [Entitic mass]

895

0.77

0.31

26.4

22.5

30.44

30.22

0.70

889

(3007461) Platelets [#/volume] in Blood

894

0.79

0.30

26.5

22.6

255.93

253.83

e9/l

0.13

881

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

705

1.22

0.29

24.5

19.1

334.49

332.97

g/l

0.80

705

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

352

1.18

0.29

2.1

2.0

103.16

98.75

pmol/l

0.16

183

(4035726) Immunohistochemistry procedure

1.25

0.28

1.4

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

823

1.31

0.27

20.1

14.9

16.27

21.75

mg/l

1.46

657

(3014576) Chloride [Moles/volume] in Serum or Plasma

114

1.27

0.27

2.9

7.1

103.57

104.82

mmol/l

0.59

114

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

771

1.24

0.26

4.9

4.5

5.70

5.81

mmol/l

0.36

721

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

750

1.22

0.26

5.5

5.6

37.80

38.75

mmol/mol

0.37

714

(3027945) Reticulocytes/Erythrocytes in Blood

0.70

0.25

1.5

3.7

1.30

1.85

—

(40768804) Tissue Pathology biopsy report

317

1.16

0.24

2.6

1.9

—

(3003694) ABO and Rh group [Type] in Blood

260

0.85

0.23

1.8

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1.26

0.23

1.2

3.6

0.94

0.83

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.26

0.22

1.6

2.1

—

(40761511) CBC panel - Blood by Automated count

848

1.31

0.22

12.1

12.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.75

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

0.21

0.0

1.1

—

0.66

—

(4146454) Self-monitoring of blood glucose

0.00

0.21

0.0

3.1

—

(3045716) Anion gap in Serum or Plasma by calculation

0.00

0.21

0.0

1.8

—

9.92

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.21

0.0

3.2

—

3.95

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

0.21

0.0

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.21

0.0

3.2

—

1.20

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.21

0.0

3.2

—

106.00

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.16

0.19

1.2

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

194

0.85

0.19

2.3

2.4

—

(3008898) HLA-B27 [Presence]

1.22

0.18

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

129

1.19

0.18

1.7

1.9

—

(3044640) Blood type and Crossmatch panel - Blood

265

0.87

0.17

2.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

151

0.84

0.17

1.5

1.6

—

(3019225) pH of Specimen

1.16

0.17

3.6

4.7

7.38

7.39

—

(36660697) Celiac disease serology panel - Serum

1.23

0.16

1.3

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

222

0.87

0.15

5.7

4.4

3.35

11.92

mg/mmol

2.09

148

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

151

1.15

0.14

1.2

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

761

1.14

0.13

4.2

3.9

1.32

1.26

mmol/l

0.35

713

(21494755) Public health laboratory ask at order entry panel

116

0.85

0.12

1.1

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

125

0.86

0.11

1.7

1.9

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1.14

0.10

1.2

3.5

2.30

1.56

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.04

0.09

1.8

1.4

—

(40761535) Cells panel - Urine sediment

1.14

0.09

2.3

3.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

146

1.12

0.09

1.3

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1.08

0.09

1.3

1.8

1.43

4.97

ug/l

—

(3026008) Bacteria identified in Urine by Culture

225

1.09

0.08

5.3

3.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

862

0.87

0.08

13.2

11.5

30.25

27.44

u/l

0.63

846

(40761536) Microorganisms panel - Urine sediment

1.05

0.08

4.4

3.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

108

1.13

0.07

3.2

3.0

0.63

0.74

ug/l

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

858

0.91

0.03

22.5

17.8

80.09

74.80

umol/l

0.41

849

(1761868) Lipid panel - Serum or Plasma

339

0.96

0.03

3.7

3.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

227

0.96

0.01

2.1

—

(3029937) Albumin [Presence] in Urine by Test strip

243

1.04

0.01

5.9

3.2

0.00

estimate

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

206

0.96

0.00

2.0

2.59

2.74

mg/l

0.17

183

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

818

1.02

0.00

5.4

5.1

2.88

2.81

mmol/l

0.25

770

(3042936) Bacteria identified in Isolate by Culture

127

1.03

0.00

3.5

1.9

—

(40768797) Stomach Pathology biopsy report

105

0.95

0.00

1.4

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

804

0.97

0.00

20.5

16.2

3.98

3.93

mmol/l

1.33

786

(3019550) Sodium [Moles/volume] in Serum or Plasma

804

0.97

0.00

20.4

16.1

139.70

139.72

mmol/l

0.02

788

(3012516) Albumin [Mass/volume] in Urine

214

0.98

0.00

4.5

3.7

15.81

72.58

mg/l

2.33

147

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(4281824) Cell count and differential, peritoneal fluid

0.00

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

0.0

1.0

—

(4211845) Urine protein measurement

0.00

0.0

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.0

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.0

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

159.64

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

4.38

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

31.13

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

4.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.00

0.0

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.0

1.0

—

0.27

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.0

1.9

—

8.44

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

0.0

1.5

—

117.25

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

0.0

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.0

2.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

0.0

1.0

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

174.20

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.0

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

0.0

1.8

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

109.94

—

(3017354) Segmented neutrophils/Leukocytes in Blood

0.00

0.0

4.4

—

68.60

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.2

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

65.20

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.4

—

119.86

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.0

1.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

-0.00

0.0

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

-0.00

0.0

1.0

—

1.36

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

6.0

—

25.52

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

-0.00

0.0

1.4

—

23.44

—

(3045142) Bone marrow Pathology biopsy report

0.00

-0.00

0.0

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

0.89

-0.00

2.4

1.6

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

4.8

—

299.00

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

2.7

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

0.00

-0.00

0.0

2.3

—

1.29

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.90

-0.00

3.3

5.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

2.7

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_EFFEC_OTHER_DEPRI – Effects of other deprivation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Effects of other deprivation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Effects of other deprivation (ST19_EFFEC_OTHER_DEPRI)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

TimeCodeWAS

LabWAS

Mortality – FinRegistry

Relationships between endpoints